Oxytocin and addiction: A review

Psychoneuroendocrinology

Volumn 23, Issue 8, 1998, Pages 945-962

  L Kovács, Gábor ^a   Sarnyai, Zoltán ^b   Szabó, Gyula ^c  

^a Markusovszky Teaching Hospital   (Hungary)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Addiction; Cocaine; Ethanol; Neuropeptides; Opiate; Oxytocin; Rapid tolerance; Withdrawal

Indexed keywords

ALCOHOL; COCAINE; DIAMORPHINE; MORPHINE; NEUROPEPTIDE; OPIATE; OXYTOCIN; OXYTOCIN RECEPTOR;

ADAPTATION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; COCAINE DEPENDENCE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HIPPOCAMPUS; HYPERACTIVITY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; OPIATE ADDICTION; OXYTOCIN RELEASE; PRIORITY JOURNAL; RAT; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ALCOHOLISM; ANIMALS; BRAIN; COCAINE-RELATED DISORDERS; HUMANS; MICE; MORPHINE DEPENDENCE; OXYTOCIN; RATS; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 18544407962     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(98)00064-X     Document Type: Conference Paper

References (66)

1. Acquas E., Di Chiara G. Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. Journal of Neurochemistry. 58:1992;1620-1625.
2. Buijs R. M. Vasopressin and oxytocin - their role in neurotransmission. Pharmacological Therapy. 22:1983;127-141.
3. Caldwell J. D., Hruby V. J., Hill P., Prange A. J., Pedersen C. A. Is oxytocin-induced grooming mediated by uterine-like receptors? Neuropeptides. 8:1986;77-86.
4. Colbern D. L., Ritzmann R. F., Krivoy W. Neurohypophyseal peptides in tolerance and dependence. De Wied D., Gispen W. H., Van Wimersma Greidanus T. J. B. Neuropeptides and Behavior. 2:1986;171-186 Pergamon Press, Oxford.
5. De Kloet E. R., Rotteveel F., Vorhouis T. A. M., Terlou M. Topography of binding sites for neurohypophyseal hormones in rat brain. European Journal of Pharmacology. 110:1985;113-119.
6. Drago F., Sarnyai Z., D'Agata V. The inhibition of oxytocin-induced grooming by a specific receptor antagonist. Physiology and Behavior. 50:1991;533-536.
7. 7]OT: a highly selective ligand for central and peripheral OT receptors. American Journal of Physiology. 254:1988;31-38.
8. 3H]oxytocin in female rat brain. Canadian Journal of Physiology and Pharmacology. 61:1983;989-995.
9. Galloway M. P. Neurochemical interactions of cocaine with dopaminergic systems. Trends in Pharmacological Science. 9:1988;451-454.
10. Hammer R. P., Egilmez Y., Emmett-Oglesby M.W. Neural mechanisms of tolerance to the effects of cocaine. Behavioral Brain Research. 84:1997;225-239.
11. Hoffman P. L., Ritzmann R. F., Walter R., Tabakoff B. Arginine vasopressin maintains ethanol tolerance. Nature. 276:1978;614-616.
12. Hökfelt T. Neuropeptides in perspectives: the last ten years. Neuron. 7:1991;867-879.
13. Ibragimov R., Kovács G. L., Szabó G., Telegdy G. Microinjection of oxytocin into limbic-mesolimbic brain structures disrupts heroin self-administration behavior: a receptor mediated event? Life Sciences. 41:1987;1264-1271.
14. Johanson, C. E. and Fischman, M. W. (1989) The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41, 3-52.
15. Jost K., Sorm F. The preparation of N-α-acetyl-[2-O-methyltyrosine]-oxytocin, a powerful inhibitor of the uterotonic activity of oxytocin. Collection of Czechoslovak Chemical Communications. 36:1971;297.
16. Kastin A. J., Nissen C., Schally A. V., Coy D. H. Blood-brain barrier, half-time disappearance, and blood distribution for labeled enkephalin and a potent analog. Life Sciences. 32:1976;295-301.
17. Király M., Audigier S., Tribollet E., Barberis C., Dolivo M., Dreifuss J. J. Biochemical and electrophysiological evidence of functional vasopressin receptors in the rat superior cervical ganglion. Proceedings of the National Academy of Science USA. 83:1986;5335-5339.
18. Koob G. F. Neural mechanisms of drug reinforcement. Annals of the New York Academy Science. 654:1992;171-191.
19. Koob G. F., Bloom F. E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
20. Koob G. F., Caine S. B., Parsons L., Markou A., Weiss F. Opponent process model and psychostimulant addiction. Pharmacology and Biochemical Behavior. 57:1997;513-521.
21. Kovács G. L. Oxytocin and behaviour. Ganten D., Pfaff D. Current Topics in Neuroendocrinology. 6:1986;90-128 Springer, Berlin.
22. Kovács G. L., Borthaiser Z., Telegdy G. Oxytocin reduces intravenous heroin self-administration in heroin-tolerant rats. Life Sciences. 37:1985;17-26.
23. Kovács G. L., Faludi M., Falkay G., Telegdy G. Peripheral oxytocin treatment modulates central dopamine transmission in the mouse limbic structures. Neurochemical International. 9:1986;481-485.
24. Kovács G. L., Izbéki F., Horváth Z., Telegdy G. Effects of oxytocin and a derivative (Z-prolyl-D-leucine) on morphine tolerance/dependence are mediated by the limbic system. Behavioral Brain Research. 14:1984;1-8.
25. Kovács G. L., Sarnyai Z., Babarczy E., Szabó G., Telegdy G. The role of oxytocin-dopamine interactions in cocaine-induced locomotor hyperactivity. Neuropharmacology. 29:1990;365-368.
26. Kovács G. L., Sarnyai Z., Izbéki F., Szabó G., Telegdy G., Barth T., Jost K., Brtnik F. Effects of oxytocin-related peptides on rapid morphine tolerance: opposite actions by oxytocin and its receptor antagonists. Journal of Pharmacology and Experimental Therapy. 241:1987;569-574.
27. Kovács G. L., Sarnyai Z., Szabó G., Telegdy G. Development of morphine tolerance is under tonic control of brain oxytocin. Drug and Alcohol Dependence. 17:1986;369-375.
28. Kovács G. L., Szontágh L., Baláspiri L., Hódi K., Bohus P., Telegdy G. On the mode of action of an oxytocin derivative (Z-Pro-D-Leu) on morphine dependence in mice. Neuropharmacology. 20:1981;647-651.
29. Kovács G. L., Telegdy G. Effects of oxytocin, desglycinamide-oxytocin and anti-oxytocin serum on the α-MPT-induced disappearance of catecholamines in the rat brain. Brain Research. 268:1983;307-314.
30. Kovács G. L., Telegdy G. Role of oxytocin in memory, amnesia and reinforcement. Amico J. A., Robinson A. G. Oxytocin Clinical and Laboratory Studies. 1985;359-371 Elsevier, Amsterdam.
31. Kovács G. L., Telegdy G. Endorphin tolerance is inhibited by oxytocin. Pharmacology and Biochemical Behavior. 26:1987;57-60.
32. Kovács G. L., Telegdy G. Neurohypophyseal peptides, motivated and drug-induced behaviour. Frontiers in Hormone Research. 15:1987;138-174.
33. Kovács G. L., Van Ree J. M. Behaviourally active oxytocin fragments simultaneously attenuate heroin self-administration and tolerance in rats. Life Sciences. 37:1985;1895-1900.
34. Kow L. M., Pfaff D. W. Neuromodulatory actions of peptides. Annual Reviews in Pharmacology and Toxicology. 28:1988;163-188.
35. Krejci I., Kupková B., Barth T. N-α-acetyl-(2-O-methyltyrosine)-oxytocin: a specific antagonist of oxytocin. Acta Physiologia Bohemoslovenica. 22:1973;315-322.
36. Krejci I., Kupkova B., Barth T., Jost K. N-acetyl-2-O-methyl-tyrosine-oxytocin: a specific antagonist of oxytocin. Physiologia Bohemoslovenica. 22:1973;315-322.
37. 9-lysine vasopressin. Proceedings of the National Academy of Science USA. 71:1974;1852-1856.
38. Kuhar M. J., Ritz M. C., Boja J. W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends in Neuroscience. 14:1991;299-302.
39. Lange D. G., Roerig S. C., Fujimoto J. M., Busse L. W. Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice. Journal of Pharmacology and Experimental Therapy. 224:1983;13-20.
40. Lindvall O., Björklund A. Organization of catecholamine neurones in the rat central nervous system. Iversen L. L., Iversen S. D., Snyder S. H. Handbook of Psychopharmacology. 9:1978;130-231 Plenum Press, New York.
41. Lowinson J. H., Ruiz P., Millman R. B., Langrod J. G. Substance Abuse. A Comprehensive Textbook. 1992;Williams and Wilkins, Baltimore.
42. Madras B. K. Dopamine. Lajtha A. Receptors in the Central Nervous System Handbook of Neurochemistry. 6:1984;71-103 Plenum Press, New York.
43. Mens, W. B. J. (1982) Neurohypophyseal hormones in blood, cerebrospinal fluid and brain of the rat. Ph.D. thesis. University of Utrecht.
44. Redmond D. E., Krystal J. H. Multiple mechanisms of withdrawal from opioid drugs. Annual Reviews in Neuroscience. 7:1984;443-478.
45. Sarnyai Z. Measurement of cocaine-induced stereotyped behavior in response to neuropeptides. Conn P. M. Methods in Neurosciences Paradigms for the Study of Behavior. 14:1993;153-165 Academic Press, San Diego, CA.
46. Sarnyai Z., Babarczy E., Kriván M., Szabó G., Kovács G. L., Barth T., Telegdy G. Selective attenuation of cocaine-induced stereotyped behaviour by oxytocin: putative role of basal forebrain target sites. Neuropeptides. 19:1991;51-56.
47. Sarnyai, Z., Bíró, É., Babarczy, E., Vecsernyés, M., Laczi, F., Szabó, G., Kriván, M., Kovács, G. L. and Telegdy, G. (1992a) Oxytocin modulates behavioural adaptation to repeated treatment with cocaine in rats. Neuropharmacology 31, 593-598.
48. Sarnyai Z., Kovács G. L. Role of oxytocin in the neuroadaptation to drugs of abuse. Psychoneuroendocrinology. 19:1994;85-117.
49. Sarnyai Z., Szabó G., Kovács G. L., Telegdy G. Oxytocin attenuates the cocaine-induced exploratory hyperactivity in mice. NeuroReport. 1:1990;200-202.
50. Sarnyai Z., Szabó G., Kovács G. L., Telegdy G. Opposite actions of oxytocin and vasopressin in the development of cocaine-induced behavioral sensitization in mice. Pharmacology and Biochemical Behavior. 43:1992;491-494.
51. Sarnyai, Z., Vecsernyés, M., Laczi, F., Bíró, É., Szabó, G. and Kovács, G. L. (1992c) Effects of cocaine on the contents of neurohypophyseal hormones in the plasma and in different brain structures in rats. Neuropeptides 23, 27-31.
52. Sarnyai Z., Viski S., Kriván M., Szabó G., Kovács G. L., Telegdy G. Endogenous oxytocin inhibits morphine tolerance through limbic forebrain receptors. Brain Research. 463:1988;284-288.
53. Sawchenko P. E., Swanson L. W. Relationship of oxytocin pathways to the control of neuroendocrine and autonomic functions. Amico J. A., Robinson A. G. Oxytocin Clinical and Laboratory Studies. 1985;87-104 Elsevier, Amsterdam.
54. Shewey L. M., Dorsa D. M. V1-type vasopressin receptors in rat brain septum: binding characteristics and effects on inositol phospholipid metabolism. Journal of Neuroscience. 8:1988;1671-1677.
55. Sim L. J., Morris M. Activation of c-fos in PVN oxytocin neurons exposed to cocaine and dopamine. Society for Neuroscience Abstracts. 18:1992;346.
56. Szabó G., Kovács G. L., Székeli S., Telegdy G. The effects of neurohypophyseal hormones on tolerance to the hypothermic effect of ethanol. Alcohol. 2:1985;567-674.
57. Szabó G., Kovács G. L., Telegdy G. Effects of neurohypophyseal peptide hormones on alcohol dependence and withdrawal. Alcohol and Alcoholism. 22:1987;71-74.
58. Szabó G., Kovács G. L., Telegdy G. Nurohypophyseal peptides and ethanol tolerance and dependence. Frontiers in Hormone Research. 15:1987;128-137.
59. Szabó G., Kovács G. L., Telegdy G. Brain monoamines are involved in mediating the action of neurohypophyseal peptide hormones on ethanol tolerance. Acta Physiologia Hungaricae. 71:1988;459-466.
60. Szabó G., Kovács G. L., Telegdy G. Intraventricular administration of neurohypophyseal hormones interferes with the development of tolerance to ethanol. Acta Physiologia Hungaricae. 73:1989;97-103.
61. Tribollet E., Barberis C., Jard S., Dubois-Dauphin M., Dreifuss J. J. Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography. Brain Research. 442:1988;105-118.
62. Van Heuven-Nolsen D., De Kloet E. R., Versteeg D. H. G. Oxytocin affects noradrenaline utilization in distinct limbic-forebrain regions of the rat brain. Neuropharmacology. 23:1984;1373-1377.
63. Van Ree J. M. Neuropeptides and addictive behavior. Alcohol and Alcoholism. 18:1983;325-330.
64. Van Ree J. M., De Wied D. Heroin self-administration is under control of vasopressin. Life Sciences. 21:1977;315-320.
65. Van Ree J. M., De Wied D. Effect of neurohypophyseal hormones on morphine dependence. Psychoneuroendocrinology. 2:1977;35-41.
66. Versteeg D. H. G. Neurohypophyseal hormones and brain neurochemistry. Pharmacological Therapy. 19:1983;297-325.